2024-03-08 00:30:17 ET
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)
Q4 2023 Earnings Call
Mar 07, 2024 , 4:30 p.m. ET
Operator
For further details see:
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript2024-03-08 00:30:17 ET
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)
Q4 2023 Earnings Call
Mar 07, 2024 , 4:30 p.m. ET
Operator
For further details see:
MacroGenics (MGNX) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The rev...
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-qua...
MacroGenics, Inc. (NASDAQ: MGNX) is one of today's top gainers. The company's shares have moved 28.68% on the day to $17.59. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MAR...